To read the full story visit To find out more about chlamydia visit …
Hi I'm Josephine and welcome to Behind
the Headlines, the science behind the news.
This week The Guardian reported
that a vaccine to protect against chlamydia
has moved closer to becoming a reality after a pioneering clinical trial found the treatment to be safe.
Chlamydia is one of the most common sexually
transmitted infections.
It can be easily treated with antibiotics though most people don't notice any symptoms and so
they don't realise that they have it.
If left untreated chlamydia can lead to infertility in both men and women.
You can find out more about chlamydia by clicking the link.
The pioneering
trial lasted over the course of five months
giving 35 women five doses of
either a new chlamydia vaccine or a
dummy treatment known as a placebo.
All of the women who were given the vaccine
started to produce infection-fighting
antibodies.
This suggests that if they were exposed to chlamydia bacteria, they'd likely
produce antibodies to attack and destroy it.
Although these findings are really promising, further testing involving more people
is needed to make sure the vaccine is safe and effective.
If you want to reduce your
risk of getting chlamydia as well as
most other STI's, always use a condom
during sex including oral and anal sex.
If you want to find out more about
this story please click on the link.

Leave A Comment

Your email address will not be published
*